Therapeutic surfactant-stripped frozen micelles

Citations Over TimeTop 10% of 2016 papers

Abstract

Injectable hydrophobic drugs are typically dissolved in surfactants and non-aqueous solvents which can induce negative side-effects. Alternatives like 'top-down' fine milling of excipient-free injectable drug suspensions are not yet clinically viable and 'bottom-up' self-assembled delivery systems usually substitute one solubilizing excipient for another, bringing new issues to consider. Here, we show that Pluronic (Poloxamer) block copolymers are amenable to low-temperature processing to strip away all free and loosely bound surfactant, leaving behind concentrated, kinetically frozen drug micelles containing minimal solubilizing excipient. This approach was validated for phylloquinone, cyclosporine, testosterone undecanoate, cabazitaxel and seven other bioactive molecules, achieving sizes between 45 and 160 nm and drug to solubilizer molar ratios 2-3 orders of magnitude higher than current formulations. Hypertonic saline or co-loaded cargo was found to prevent aggregation in some cases. Use of surfactant-stripped micelles avoided potential risks associated with other injectable formulations. Mechanistic insights are elucidated and therapeutic dose responses are demonstrated.

Related Papers

• → Selection of solid dosage form composition through drug–excipient compatibility testing(1999)200 cited
• → Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example(2011)15 cited
• → Development and validation of a system for the prediction of excipient-excipient incompatibility using machine learning tools(2022)2 cited
• → Reverse Micelles, Enzymes(1999)
• → Prediction of excipient-excipient incompatibility: A latent threat to pharmaceutical product development(2022)